found activating mutations and amplification of the Ras oncogene, which was an upstream activator of the Raf/Mek/Erk1/Erk2 kinase pathway, a typical MAPK pathway, in cSCC (35). The gene discussed is MAPK3; the disease is skin squamous cell carcinoma.